CFTR and cystic fibrosis: Although the link between plasma membrane alteration of CF patients and TRPV2 activity is not resolved, a therapeutic strategy for increasing TRPV2 activity could be considered, in the same way that it could be done to restore CFTR activity with ivacaftor39.